The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study

Affiliation auteurs!!!! Error affiliation !!!!
TitreThe real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study
Type de publicationJournal Article
Year of Publication2019
AuteursAmiot A., Serrero M., Peyrin-Biroulet L., Filippi J., Pariente B., Roblin X., Buisson A., Stefanescu C., Trang-Poisson C., Altwegg R., Marteau P., Vaysse T., Bourrier A., Nancey S., Laharie D., Allez M., Savoye G., Moreau J., Vuitton L., Viennot S., Aubourg A., Pelletier A.-L, Bouguen G., Abitbol V., Fumery M., Gagniere C., Bouhnik Y.
JournalJOURNAL OF CROHNS & COLITIS
Volume13
PaginationS476-S477
Date PublishedMAR
Type of ArticleMeeting Abstract
ISSN1873-9946
DOI10.1093/ecco-jcc/jjy222.835